Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

April 25, 2015 - 1:00 a.m.
Gilead Announces Results From Studies Evaluating Sofosbuvir-Based Regimens in Chronic Hepatitis C Patients With Genotypes 2-5Printer Friendly Version 
April 23, 2015 - 5:02 p.m.
Gilead Sciences to Release First Quarter 2015 Financial Results on Thursday, April 30, 2015Printer Friendly Version 

Upcoming Events

Wednesday, April 22, 2015 through Sunday, April 26, 2015
50th Annual Meeting of the European Association for the Study of the Liver (EASL): The International Liver Congress 2015
LocationVienna, Austria
Thursday, April 30, 2015 1:30 p.m. PT
First Quarter 2015 Gilead Sciences Earnings Conference Call
Wednesday, May 6, 2015
Gilead Sciences 2015 Annual Stockholders Meeting
LocationMillbrae, CA
Wednesday, May 13, 2015 through Saturday, May 16, 2015
Heart Rhythm Society (HRS)
LocationBoston, MA
Friday, May 15, 2015 through Wednesday, May 20, 2015
American Thoracic Society (ATS)
LocationDenver, CO
Saturday, May 16, 2015 through Tuesday, May 19, 2015
Digestive Disease Week (DDW)
LocationWashington, DC

Most Viewed Links

Updated 04/27/15
1.Earnings
2.SEC Filings
3.Stock Information
4.Annual Reports
5.Fundamentals - Snapshot
* Data collected 04/19/15 - 04/26/15

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
$103.70
 Stock is Down 1.51 (1.43%)
Data as of 04/24/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Fourth Quarter 2014 Gilead Sciences Earnings Conference Call

February 03, 2015 1:30 p.m. PT
Play